Progenics Class Action: Halper Sadeh LLP Announces Filing Of Shareholder Class Action Lawsuit Against Progenics Pharmaceuticals, Inc.; Investors Are Encouraged To Contact The Firm

NEW YORK, May 8, 2020

If you are a Progenics shareholder and would like to join the action or discuss your legal rights and options, please visit Progenics Class Action or contact Daniel Sadeh or Zachary Halper, free of charge, at (212) 763-0060 or sadeh@halpersadeh.com or zhalper@halpersadeh.com.

The lawsuit alleges that Defendants issued a materially misleading registration statement recommending that Progenics shareholders vote in favor of the proposed merger between Progenics and Lantheus. According to the complaint, the registration statement contains materially incomplete and misleading information concerning, among other things, Progenics' financial projections and the analyses performed by Progenics' financial advisor. 

If you wish to serve as lead plaintiff, you must move the Court no later than June 22, 2020. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. If you would like to join the action or discuss your legal rights and options, please visit https://halpersadeh.com/actions/progenics-pharmaceuticals-inc-pgnx-stock-merger-lantheus/ or contact Daniel Sadeh or Zachary Halper, free of charge, at (212) 763-0060 or sadeh@halpersadeh.com or zhalper@halpersadeh.com.

NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU MAY RETAIN COUNSEL OF YOUR CHOICE OR YOU MAY REMAIN AN ABSENT CLASS MEMBER AND DO NOTHING AT THIS POINT.

Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.